Because regulatory approval of cognitive enhancement drugs is likely, physicians may want to consider whether they would condone the practice for restoration of function only or for enhancement purposes as well.
Should physicians engage beliefs and practices that do not agree with their medical judgment as a means to securing patient adherence to recommended treatment?
Physicians who base end-of-life care decisions for patients on their own preferences may offer less treatment than the patients themselves would have wanted.